Companies: 10,795·Total market cap: $144.5T
Molecular Partners AG

Molecular Partners AG

MOLNNASDAQHealthcare● Active
$3.95
$-0.15(-3.66%)
Market Cap$148168932
P/E Ratio—
52W High$5.36
52W Low$3.41
SEC Filings
Foreign Private Issuer · Files 20-F / 6-K

Molecular Partners AG (MOLN) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001745114 · MOLN · NASDAQ · as of Jun 8, 2026

Filing snapshot

115
Total Filings
6-K
Latest Form
2026-06-01
Most Recent
2021
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001745114 · Updated hourly · Not investment advice

Latest Annual Report

20-F · Annual Report (Foreign Issuer)FY
Filed Date
2026-03-12
Fiscal Year End
Mar 12, 2026
Accession No.
0001745114-26-000009
Primary Document
moln-20251231.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001745114 · Accession 0001745114-26-000009

Latest Key Filings

6-KQuarterly Report
FORM 6-K
2026-06-01
View 6-K on SEC
8-KCurrent Report

No recent filings

Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-06-01
View
6-KCurrent Report (Foreign Issuer)
6-K
2026-05-12
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-05-01
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-04-14
View
6-KCurrent Report (Foreign Issuer)
6-K
2026-03-30
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-03-13
View
6-KCurrent Report (Foreign Issuer)
6-K
2026-03-12
View
20-FAnnual Report (Foreign Issuer)
20-F
2026-03-12
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-02-02
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-01-12
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2025-12-08
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2025-11-12
View
6-KCurrent Report (Foreign Issuer)
6-K
2025-10-30
View
6-KCurrent Report (Foreign Issuer)
6-K
2025-08-25
View
SCHEDULE 13GSCHEDULE 13G
SCHEDULE 13G
2025-07-17
View
Showing 1–15 of 115 filingsForm 4 / 144 hidden

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001745114  |  Exchange: NASDAQ · Healthcare

Molecular Partners AG (NASDAQ: MOLN) has submitted 115 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2021. As a Healthcare sector company with CIK 0001745114, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Molecular Partners AG's most comprehensive regulatory disclosure. The most recent Molecular Partners AG 10-K was filed on 2026-03-12 for fiscal year ending 2026. Historical MOLN 10-K annual reports are available from 2021 through 2026.

Investors researching Molecular Partners AG SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-08
Related Companies SEC Filings — Healthcare
ELTX SEC Filings →ALEC SEC Filings →NKTX SEC Filings →MIST SEC Filings →CRDF SEC Filings →CRBP SEC Filings →PEPG SEC Filings →SAVA SEC Filings →
→ MOLN Financials→ MOLN Earnings→ MOLN Insider Trades

Frequently Asked Questions

MOLN SEC Filings · 8 questions

Molecular Partners AG (MOLN) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 115 filings and access original documents at no cost. Molecular Partners AG's CIK is 0001745114.

MOLN SEC filingsMolecular Partners AG SEC documentsfind MOLN 10-K